NeuralThera (NURL.CN)
- Previous Close
0.0400 - Open
0.0400 - Bid 0.0350 x --
- Ask --
- Day's Range
0.0300 - 0.0400 - 52 Week Range
0.0200 - 0.0500 - Volume
17,500 - Avg. Volume
82,323 - Market Cap (intraday)
3.105M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Neural Therapeutics Inc., a drug discovery company, focuses on plant-based active substances. It focuses on San Pedro, a cactus containing mescaline and delivers over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments. Neural Therapeutics Inc. was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. The company was incorporated in 2020 and is headquartered in Toronto, Canada.
www.neuraltherapeutics.caRecent News: NURL.CN
View More
Performance Overview: NURL.CN
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NURL.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NURL.CN
View MoreValuation Measures
Market Cap
3.55M
Enterprise Value
3.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-102.00%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-548.15k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
546.32k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-415.88k